ViferaXS GmbH
PrivateCompany Overview
ViferaXS GmbH is a biotechnology company that develops peptide-based T cell activators for the treatment of cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
therapeutic vaccineimmunotherapyimmunopeptidomicscancer vaccineneoepitopeT cell activatorantigen discoverypeptide vaccinebiotech R&Ddrug discoveryprecision medicinevaccine platformcancer immunotherapybiotech startupclinical oncology
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViferaXS GmbH Comparables
Compare ViferaXS GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BayVax Biotech Limited | 78% | |
| ImmuneSpec | 76% | |
| Gritstone bio | 73% | |
ViferaXS GmbH Funding Rounds
Historical fundraising activity
ViferaXS GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ViferaXS GmbH's valuation, stock price, and market status.
See something wrong or outdated?